JP2016540030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016540030A5 JP2016540030A5 JP2016540981A JP2016540981A JP2016540030A5 JP 2016540030 A5 JP2016540030 A5 JP 2016540030A5 JP 2016540981 A JP2016540981 A JP 2016540981A JP 2016540981 A JP2016540981 A JP 2016540981A JP 2016540030 A5 JP2016540030 A5 JP 2016540030A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- vortioxetine
- nalmefene
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 20
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 claims 10
- 229960005297 nalmefene Drugs 0.000 claims 10
- YQNWZWMKLDQSAC-UHFFFAOYSA-N vortioxetine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 YQNWZWMKLDQSAC-UHFFFAOYSA-N 0.000 claims 10
- 229960002263 vortioxetine Drugs 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300710 | 2013-12-20 | ||
| DKPA201300710 | 2013-12-20 | ||
| DKPA201400590 | 2014-10-16 | ||
| DKPA201400590 | 2014-10-16 | ||
| PCT/EP2014/078515 WO2015091833A1 (en) | 2013-12-20 | 2014-12-18 | Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016540030A JP2016540030A (ja) | 2016-12-22 |
| JP2016540030A5 true JP2016540030A5 (cg-RX-API-DMAC7.html) | 2018-01-18 |
| JP6448645B2 JP6448645B2 (ja) | 2019-01-09 |
Family
ID=52146489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540981A Active JP6448645B2 (ja) | 2013-12-20 | 2014-12-18 | メランコリアの特徴を伴う抑うつ障害を処置するための、カッパ−活性を伴うオピオイド受容体拮抗薬およびボルチオキセチンの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10376506B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3082815B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6448645B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160093025A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105828821B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014368548B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2933733A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2016001570A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2694352T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL246253A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX368870B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2679661C1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201604944PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015091833A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2018015759A (es) | 2016-07-01 | 2019-03-21 | H Lundbeck As | Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo. |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
| EP3876938A4 (en) * | 2018-11-06 | 2022-08-10 | Purdue Pharma L.P. | COMPOSITIONS AND METHODS OF ADMINISTRATION OF OPIOID ANTAGONISTS |
| US11266627B1 (en) | 2021-05-04 | 2022-03-08 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| CN119156202A (zh) | 2022-03-07 | 2024-12-17 | 杨森制药公司 | 包含阿替卡普兰的组合物 |
| JP2025508051A (ja) | 2022-03-07 | 2025-03-21 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 大うつ病性障害の治療に使用するためのアチカプラントの多形形態 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028612A (en) | 1990-03-22 | 1991-07-02 | Hillel Glover | Method for treating emotional numbness |
| US5013740A (en) | 1990-03-22 | 1991-05-07 | Hillel Glover | Method for treating emotional numbness and coma |
| US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
| WO2002049643A1 (en) | 2000-12-21 | 2002-06-27 | The Mclean Hospital Corporation | Treatment of depression |
| US20030087896A1 (en) * | 2001-08-09 | 2003-05-08 | Hillel Glover | Treatment of refractory depression with an opiate antagonist and an antidepressant |
| PL368612A1 (en) * | 2001-08-14 | 2005-04-04 | Biotie Therapies Corporation | Method of treating alcoholism or alcohol abuse |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| AU2003224742A1 (en) * | 2002-03-20 | 2003-10-08 | Euro-Celtique S.A. | Method of administering buprenorphine to treat depression |
| US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| WO2007064586A1 (en) * | 2005-11-28 | 2007-06-07 | Orexigen Therapeutics, Inc. | Methods of treating anxiety disorders |
| CN101432011A (zh) * | 2006-02-27 | 2009-05-13 | 亚历山大·米哈洛 | 通过诱导逆适应调节神经递质系统的方法 |
| WO2008066916A1 (en) | 2006-11-30 | 2008-06-05 | The Mclean Hospital Corporation | Methods for the treatment of mood disorders |
| CA2646899C (en) * | 2006-04-04 | 2014-05-06 | Holger Lars Hermann | Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders |
| US20070259939A1 (en) * | 2006-05-04 | 2007-11-08 | Accelerated Technologies | Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness |
| MY150647A (en) | 2006-06-16 | 2014-02-14 | Lundbeck & Co As H | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| TW200848411A (en) | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
| TW200932225A (en) * | 2007-12-14 | 2009-08-01 | Lundbeck & Co As H | 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| UA106752C2 (uk) | 2009-05-25 | 2014-10-10 | Х. Луннбек А/С | Одержання налмефену гідрохлориду з налтрексону |
| US20120302590A1 (en) * | 2009-08-13 | 2012-11-29 | The General Hospital Corporation | Methods and compositions to prevent addiction |
| US20130115292A1 (en) | 2010-04-30 | 2013-05-09 | Takeda Pharmaceutical Company Limited | Enteric tablet |
| RS55777B1 (sr) | 2010-11-05 | 2017-07-31 | H Lundbeck As | Postupak za proizvodnju naltreksona |
| EP2950799B1 (en) * | 2013-01-30 | 2019-12-04 | Pharmorx Therapeutics, Inc. | Treatments for depression and other diseases with a low dose agent |
| US20160058754A1 (en) | 2013-04-17 | 2016-03-03 | H. Lundbeck A/S | Nalmefene for Treatment of Patients with Anxiety Disorder |
| CA2909504C (en) * | 2013-04-17 | 2021-04-20 | H. Lundbeck A/S | Nalmefene for treatment of patients with mood disorder |
-
2014
- 2014-12-18 CN CN201480069586.5A patent/CN105828821B/zh active Active
- 2014-12-18 SG SG11201604944PA patent/SG11201604944PA/en unknown
- 2014-12-18 KR KR1020167016182A patent/KR20160093025A/ko not_active Withdrawn
- 2014-12-18 WO PCT/EP2014/078515 patent/WO2015091833A1/en not_active Ceased
- 2014-12-18 ES ES14818973.1T patent/ES2694352T3/es active Active
- 2014-12-18 MX MX2016007947A patent/MX368870B/es active IP Right Grant
- 2014-12-18 EP EP14818973.1A patent/EP3082815B1/en active Active
- 2014-12-18 RU RU2016123972A patent/RU2679661C1/ru not_active IP Right Cessation
- 2014-12-18 CA CA2933733A patent/CA2933733A1/en not_active Abandoned
- 2014-12-18 US US15/105,701 patent/US10376506B2/en active Active
- 2014-12-18 AU AU2014368548A patent/AU2014368548B2/en not_active Ceased
- 2014-12-18 JP JP2016540981A patent/JP6448645B2/ja active Active
-
2016
- 2016-06-15 IL IL246253A patent/IL246253A0/en unknown
- 2016-06-17 CL CL2016001570A patent/CL2016001570A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016540030A5 (cg-RX-API-DMAC7.html) | ||
| IL252596A0 (en) | History of azabicyclooctane as fxr agonists for use in the treatment of liver and gastrointestinal diseases | |
| JP2016515522A5 (cg-RX-API-DMAC7.html) | ||
| JP2016518337A5 (cg-RX-API-DMAC7.html) | ||
| HUE066591T2 (hu) | 8-ciano-5-piperidino-kinolinok, mint TLR7/8 antagonisták és alkalmazásuk immunrendellenességek kezelésére | |
| JP2015503422A5 (cg-RX-API-DMAC7.html) | ||
| MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
| JP2014530840A5 (cg-RX-API-DMAC7.html) | ||
| WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
| JP2016535100A5 (cg-RX-API-DMAC7.html) | ||
| HUE036084T2 (hu) | Buprenorfin dimer és alkalmazása gasztrointesztinális rendellenességek kezelésénél | |
| ZA201704026B (en) | Oral octreotide administered in combination with other therapeutic agents | |
| JP2016540026A5 (cg-RX-API-DMAC7.html) | ||
| HUE046924T2 (hu) | Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra | |
| HUE045025T2 (hu) | Heterobiciklusos vegyületek és alkalmazásuk tuberkulózis kezelésére | |
| JP2016540019A5 (cg-RX-API-DMAC7.html) | ||
| SI3157522T1 (sl) | Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| TWD172918S (zh) | 刀型玩具之部分 | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| JP2019518052A5 (cg-RX-API-DMAC7.html) | ||
| IL248428B (en) | 3,1-propanedisulfonic acid or its pharmaceutically acceptable salt for use in the treatment of sarcoidosis | |
| JP2017516883A5 (cg-RX-API-DMAC7.html) | ||
| HRP20180819T1 (hr) | Farmaceutski pripravak sildenafil-citrata u obliku suspenzije namijenjene oralnoj upotrebi | |
| PT3007683T (pt) | Composição para administração oral de magnésio, em associação com uma composição para o tratamento de diabetes tipo 2 e suas complicações |